| [1] WILSON DM 3RD, COOKSON MR, VAN DEN BOSCH L, et al. Hallmarks of neurodegenerative diseases. Cell. 2023;186(4):693-714. [2]	FINDLAY MC, KHAN M, KUNDU M, et al. Innovative Discoveries in Neurosurgical Treatment of Neurodegenerative Diseases: A Narrative Review. Curr Alzheimer Res. 2023;20(6):394-402.
 [3]	JOMOVA K, RAPTOVA R, ALOMAR SY, et al. Reactive oxygen species, toxicity, oxidative stress, and antioxidants: chronic diseases and aging. Arch Toxicol. 2023;97(10):2499-574.
 [4]	CHAUDHARY MR, CHAUDHARY S, SHARMA Y, et al. Aging, oxidative stress and degenerative diseases: mechanisms, complications and emerging therapeutic strategies. Biogerontology. 2023;24(5):          609-662.
 [5]	REHMAN MU, SEHAR N, DAR NJ, et al. Mitochondrial dysfunctions, oxidative stress and neuroinflammation as therapeutic targets for neurodegenerative diseases: An update on current advances and impediments. Neurosci Biobehav Rev. 2023;144:104961.
 [6]	MACHIELA E, LIONTIS T, DUES DJ, et al. Disruption of mitochondrial dynamics increases stress resistancethrough activation of multiple stress response pathways. FASEB J. 2020;34(6):8475-8492.
 [7]	KOWALTOWSKI AJ, MENEZES-FILHO SL, ASSALI EA, et al. Mitochondrial morphology regulates organellar Ca2+ uptake and changes cellular Ca2+ homeostasis. FASEB J. 2019;33(12):13176-13188.
 [8]	QUINTANA-CABRERA R, SCORRANO L. Determinants and outcomes of mitochondrial dynamics. Mol Cell. 2023;83(6):857-876.
 [9]	CHEN W, ZHAO H, LI Y. Mitochondrial dynamics in health and disease: mechanisms and potential targets. Signal Transduct Target Ther. 2023;8(1):333.
 [10]	GREL H, WOZNICA D, RATAJCZAK K, et al. Mitochondrial Dynamics in Neurodegenerative Diseases: Unraveling the Role of Fusion and Fission Processes. Int J Mol Sci. 2023;24(17):13033.
 [11]	GUO Y, GUAN T, SHAFIQ K, et al. Mitochondrial dysfunction in aging. Ageing Res Rev. 2023;88:101955.
 [12]	MAKINDE E, MA L, MELLICK GD, et al. Mitochondrial Modulators: The Defender. Biomolecules. 2023;13(2):226.
 [13]	CURIESES ANDRÉS CM, PÉREZ DE LA LASTRA JM, ANDRéS JUAN C,
 et al. From reactive species to disease development: Effect of oxidants and antioxidants on the cellular biomarkers. J Biochem Mol Toxicol. 2023;37(11):e23455.
 [14]	SAHA S, SASO L. Pharmacological Modulation of Oxidative Stress. Int J Mol Sci. 2023;24(19):14455.
 [15]	GÓMEZ J, MOTA-MARTORELL N, JOVÉ M, et al. Mitochondrial ROS production, oxidative stress and aging within and between species: Evidences and recent advances on this aging effector. Exp Gerontol. 2023;174:112134.
 [16]	CHEN WM, CHIANG JC, SHANG Z, et al. DNA-PKcs and ATM modulate mitochondrial ADP-ATP exchange as an oxidative stress checkpoint mechanism. EMBO J. 2023;42(6):e112094.
 [17]	CHOWDHURY A, WITTE S, AICH A. Role of Mitochondrial Nucleic Acid Sensing Pathways in Health and Patho-Physiology. Front Cell Dev Biol. 2022;10:796066.
 [18]	GUO Y, ZHANG H, YAN C, et al. Small molecule agonist of mitochondrial fusion repairs mitochondrial dysfunction. Nat Chem Biol. 2023;19(4): 468-477.
 [19]	HUANG C, DENG K, WU M. Mitochondrial cristae in health and disease. Int J Biol Macromol. 2023;235: 123755.
 [20]	MANGRULKAR SV, WANKHEDE NL, KALE MB, et al. Mitochondrial Dysfunction as a Signaling Target for Therapeutic Intervention in Major Neurodegenerative Disease. Neurotox Res. 2023;41(6): 708-29.
 [21]	李苏垚,郭敏芳,于婧文,等.圣草酚对过氧化氢所致SH-SY5Y细胞线粒体动力学失衡及凋亡的影响 [J].中国组织工程研究,2022, 26(31):4975-4781.
 [22]	MA RH, ZHANG XX, NI ZJ, et al. Lycium barbarum  as functional food: a review of its nutrition, phytochemical structure, biological features, and food industry prospects. Crit Rev Food Sci Nutr. 2023;63(30):                10621-10635.
 [23]	TEIXEIRA F, SILVA AM, DELERUE-MATOS C, et al. Lycium barbarum Berries (Solanaceae) as Source of Bioactive Compounds for Healthy Purposes: A Review. Int J Mol Sci. 2023;24(5):4777.
 [24]	QI Y, DUAN G, FAN G, et al. Effect of Lycium barbarum polysaccharides on cell signal transduction pathways. Biomed Pharmacother. 2022;147: 112620.
 [25]	PENG Y, ZHAO L, HU K, et al. Anti-Fatigue Effects of Lycium barbarum Polysaccharide and Effervescent Tablets by Regulating Oxidative Stress and Energy Metabolism in Rats. Int J Mol Sci. 2022;23(18): 10920.
 [26]	JIANG Z, ZENG Z, HE H, et al. Lycium barbarum glycopeptide alleviates neuroinflammation in spinal cord injury via modulating docosahexaenoic acid to inhibiting MAPKs/NF-kB and pyroptosis pathways. J Transl Med. 2023;21(1):770.
 [27]	JIANG SJ, XIAO X, LI J, et al. Lycium barbarum polysaccharide-glycoprotein ameliorates ionizing radiation-induced epithelial injury by regulating oxidative stress and ferroptosis via the Nrf2 pathway. Free Radic Biol Med. 2023;204:84-94.
 [28]	王玉银,魏文悦,郭敏芳,等.枸杞多糖通过抑制TLR4/NF-κB信号通路促进LPS诱导的BV2小胶质细胞M2型极化[J].细胞与分子免疫学杂志,2021,37(12):1066-1072.
 [29]	GAO J, CHEN C, LIU Y, et al. Lycium barbarum polysaccharide improves traumatic cognition via reversing imbalance of apoptosis/regeneration in hippocampal neurons after stress. Life Sci. 2015;121:124-134.
 [30]	NGUYEN K, SANCHEZ CL, BRAMMER-ROBBINS E, et al. Neurotoxicity assessment of QoI strobilurin fungicides azoxystrobin and trifloxystrobin in human SH-SY5Y neuroblastoma cells: Insights from lipidomics and mitochondrial bioenergetics. Neurotoxicology. 2022;91:290-304.
 [31]	YU XD, LUO ZJ, ZHANG L, et al. Effects of olfactory ensheathing cells on hydrogen peroxide-induced apoptosis in cultured dorsal root ganglion neurons. Chin Med J (Engl). 2007;120(16):1438-1443.
 [32]	CIPRIANI S, BAKSHI R, SCHWARZSCHILD MA. Protection by inosine in a cellular model of Parkinson’s disease. Neuroscience. 2014;274: 242-249.
 [33]	BALOGOU AA, DOH A, GRUNITZKY KE. Affections neurologiques et endémie goitreuse: analyse comparative de deux provinces du Togo [Neurological disorders and endemic goiter: comparative analysis of 2 provinces in Togo]. Bull Soc Pathol Exot. 2001;94(5):406-410.
 [34]	TEMPLE S. Advancing cell therapy for neurodegenerative diseases. Cell Stem Cell. 2023;30(5):512-529.
 [35]	GUPTA R, ADVANI D, YADAV D, et al. Dissecting the Relationship Between Neuropsychiatric and Neurodegenerative Disorders. Mol Neurobiol. 2023;60(11):6476-6529.
 [36]	HAJAM YA, RANI R, GANIE SY, et al. Oxidative Stress in Human Pathology and Aging: Molecular Mechanisms and Perspectives. Cells. 2022;11(3):552.
 [37]	ASHOK A, ANDRABI SS, MANSOOR S, et al. Antioxidant Therapy in Oxidative Stress-Induced Neurodegenerative Diseases: Role of Nanoparticle-Based Drug Delivery Systems in Clinical Translation. Antioxidants (Basel). 2022;11(2):408.
 [38]	BJØRKLUND G, SHANAIDA M, LYSIUK R, et al. Natural Compounds and Products from an Anti-Aging Perspective. Molecules. 2022;27(20):7084.
 [39]	DZHALILOVA DS, MAKAROVA OV. The Role of Hypoxia-Inducible Factor in the Mechanisms of Aging. Biochemistry (Mosc). 2022;87(9):  995-1014.
 [40]	UMARE MD, WANKHEDE NL, BAJAJ KK, et al. Interweaving of reactive oxygen species and major neurological and psychiatric disorders. Ann Pharm Fr. 2022;80(4):409-425.
 [41]	STEINERT JR, AMAL H. The contribution of an imbalanced redox signalling to neurological and neurodegenerative conditions. Free Radic Biol Med. 2023;194:71-83.
 [42]	KWOK SS, BU Y, LO AC, et al. A Systematic Review of Potential Therapeutic Use of Lycium Barbarum Polysaccharides in Disease. Biomed Res Int. 2019;2019: 4615745.
 [43]	ZHU S, LI X, DANG B, et al. Lycium Barbarum polysaccharide protects HaCaT cells from PM2.5-induced apoptosis via inhibiting oxidative stress, ER stress and autophagy. Redox Rep. 2022;27(1):32-44.
 [44]	MONZEL AS, ENRíQUEZ JA, PICARD M. Multifaceted mitochondria: moving mitochondrial science beyond function and dysfunction. Nat Metab. 2023;5(4):546-562.
 [45]	XU H, LIU YY, LI LS, et al. Sirtuins at the Crossroads between Mitochondrial Quality Control and Neurodegenerative Diseases: Structure, Regulation, Modifications, and Modulators . Aging Dis. 2023;14(3):794-824.
 [46]	SU É, VILLARD C, MANNEVILLE JB. Mitochondria: At the crossroads between mechanobiology and cell metabolism. Biol Cell. 2023;115(9): e2300010.
 [47]	CHANDHOK G, LAZAROU M, NEUMANN B. Structure, function, and regulation of mitofusin-2 in health and disease. Biol Rev Camb Philos Soc. 2018;93(2):933-949.
 [48]	SERASINGHE MN, CHIPUK JE. Mitochondrial Fission in Human Diseases. Handb Exp Pharmacol. 2017;240:159-188.
 [49]	LAKSHMANAN Y, WONG FSY, SO KF, et al. Potential role of Lycium barbarum polysaccharides in glaucoma management: evidence from preclinical in vivo studies. Neural Regen Res. 2023;18(12):2623-2632.
 [50] BERTHOLET AM, DELERUE T, MILLET AM, et al. Mitochondrial fusion/fission dynamics in neurodegeneration and neuronal plasticity. Neurobiol Dis. 2016;90:3-19.
 |